Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
November 30, 2017
Semma Therapeutics raises a $114,000,000 series B round from Eight Roads Ventures.
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
A startup looking to reverse type 1 diabetes just raised $114 million
Lydia Ramsey
Web
R.I. biotech firm, CytoSolv, acquired by Semma Therapeutics
Richard Asinof
Web
What You Need to Know About Semma Therapeutics
BioSpace
Web
News
Title
Author
Date
Publisher
Description
Research and Markets
January 7, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Stem Cell Therapy Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering....
Organization
CompanyCompany attributes
Biotechnology
Stem cell
Regenerative medicine
Biopharmaceutical
Healthcare
Medicine
Cambridge, Massachusetts
United States
BostonCompany Operating Status
Active
Novartis
Eight Roads Ventures
JDRF T1D FundFounded Date
2015
Phone Number
+16173416100
Total Funding Amount (USD)
114,000,000
Latest Funding Round Date
November 30, 2017
Latest Funding Type
Series B roundCategories
Related Topics
Contributors
- 1
Dawson Sewell
Writing about startups. - 2
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 3
Keeri Tramm
Accomplished manager, brand communicator, and burgeoning data analyst. - 4
Katrina-Kay Pettitt
Data Duchess @ Golden - 5
Henry Ogolla
Passionate about reading and writing. - 6
Amy Sar
Data acquisition Golden, computational linguist - 7
Ирина Носкова
Programmer